GLP1R and metabolic dysfunction-associated steatotic liver disease: They include bariatric surgery, treatment with thiazolidinediones, glucagon-like peptide-1 receptor agonists and sodium–glucose cotransporter-2 inhibitors, all of which showed a promising effect against NAFLD [26].